back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2018-11-26 Tx date 2018-11-13 |
$GGB
Xanthic Biopharma Inc. (d.b.a. Green Growth Brands) |
Galitsky, Igor
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
+89,500 vol |
1,046,583 | |
| Filed 2018-11-26 Tx date 2018-11-13 |
$GGB
Xanthic Biopharma Inc. (d.b.a. Green Growth Brands) |
Galitsky, Igor
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-89,500 vol |
0 | |
| Filed 2018-11-12 Tx date 2018-11-09 |
$GGB
Xanthic Biopharma Inc. (d.b.a Green Growth Brands Ltd.) |
Galitsky, Igor
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-2,871,251 vol |
957,083 | |
| Filed 2018-11-12 Tx date 2018-11-09 |
$GGB
Xanthic Biopharma Inc. (d.b.a Green Growth Brands Ltd.) |
Galitsky, Igor
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-268,500 vol |
89,500 | |
| Filed 2018-11-12 Tx date 2018-02-16 |
$GGB
Xanthic Biopharma Inc. (d.b.a Green Growth Brands Ltd.) |
Galitsky, Igor
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-35,000,000 vol |
5,000,000 | |
| Filed 2018-08-15 Tx date 2018-08-06 |
$PTX
Platinex Inc. |
Galitsky, Igor
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$70,000
+1,000,000 vol $0.07 each |
1,000,000 | |
| Filed 2018-08-15 Tx date 2018-08-02 |
$PTX
Platinex Inc. |
Galitsky, Igor
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-08-15 Tx date 2018-08-06 |
$PTX
Platinex Inc. |
Galitsky, Igor
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-03-14 Tx date 2018-03-13 |
$
Xanthic Biopharma Inc. (formerly Aurquest Resources Inc) |
Galitsky, Igor
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-146,458.25
-1,171,666 vol $0.125 each |
38,828,334 | |
| Filed 2018-02-28 Tx date 2018-02-28 |
$
Xanthic Biopharma Inc. (formerly Aurquest Resources Inc) |
Galitsky, Igor
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$44,750
+358,000 vol $0.125 each |
358,000 | |
| Filed 2018-02-28 Tx date 2017-12-15 |
$
Xanthic Biopharma Inc. (formerly Aurquest Resources Inc) |
Galitsky, Igor
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-01-02 Tx date 2017-12-15 |
$
Aurquest Resources Inc. |
Galitsky, Igor
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
40,000,000 |